• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERZ NORTH AMERICA, INC. COAPTITE INJECTABLE IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERZ NORTH AMERICA, INC. COAPTITE INJECTABLE IMPLANT Back to Search Results
Catalog Number 8005P10
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Urinary Tract Infection (2120)
Event Date 05/03/2010
Event Type  Injury  
Manufacturer Narrative
The device history records for the reported lot were reviewed.All required testing specifications were met prior to release.There were no abnormalities noted.Device not returned to the manufacturer.
 
Event Description
The patient was enrolled in the coaptite injectable implant study for stress urinary incontinence.On (b)(6) 2009 the patient was injected with 2.0ml of coaptite, lots 1011520 & 1010803.No adverse event reported.On (b)(6) 2009 the patient was injected with 3.0ml of coaptite, lot 1012109.On (b)(6) 2010 the patient had a urinary tract infection (diagnosed by urine c and s).On (b)(6) 2010 the patient was prescribed macrobid 100mg bid x 7 days, then 1 qhs #45.As of (b)(6) 2010 the event was resolved.The physician assessed the event as mild and probably not device related.On (b)(6) 2010 the patient was injected with 3.0ml of coaptite, lot 1015082.On (b)(6) 2010 the patient had a urinary tract infection (diagnosed by urine c and s).On (b)(6) 2010 the patient was prescribed macrobid 100mg bid x 7 days, then 1 qhs #45.As of (b)(6) 2010 the event was resolved.The physician assessed the event as mild and probably not device related.On (b)(6) 2012 the patient had a urinary tract infection that was diagnosed by a urinalysis.On (b)(6) 2012 the patient was prescribed ciprofloxacin 400mg ivpb.The patient was admitted and ceftriaxone was administered by iv as well as rocephin iv.The patient was also given omnicef 300mgpo bid.The physician assessed the event as severe and probably not device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAPTITE INJECTABLE IMPLANT
Type of Device
INJECTABLE IMPLANT
Manufacturer (Section D)
MERZ NORTH AMERICA, INC.
4133 courtney rd
franksville WI 53126
Manufacturer (Section G)
MERZ NORTH AMERICA, INC.
4133 courtney rd
franksville WI 53126
Manufacturer Contact
ann metz
4133 courtney rd
6501 six forks rd, NC 27616
9195828000
MDR Report Key5189952
MDR Text Key29925125
Report Number2135225-2015-00090
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/31/2012
Device Catalogue Number8005P10
Device Lot Number1012109
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/29/2015
Initial Date FDA Received10/29/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/17/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient Weight84
-
-